NO20055616L - Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug - Google Patents

Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug

Info

Publication number
NO20055616L
NO20055616L NO20055616A NO20055616A NO20055616L NO 20055616 L NO20055616 L NO 20055616L NO 20055616 A NO20055616 A NO 20055616A NO 20055616 A NO20055616 A NO 20055616A NO 20055616 L NO20055616 L NO 20055616L
Authority
NO
Norway
Prior art keywords
drug
agent
antimicrobial
formulation
against organisms
Prior art date
Application number
NO20055616A
Other languages
Norwegian (no)
Other versions
NO20055616D0 (en
Inventor
James E Kipp
Joseph Chung Tak Wong
Mark J Doty
Christine L Rebbeck
Chong-Son Sun
Pavlos Papadopoulos
Barrett E Rabinow
Randy White
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO20055616D0 publication Critical patent/NO20055616D0/en
Publication of NO20055616L publication Critical patent/NO20055616L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

Foreliggende oppfinnelse gjelder preparater av partikler av submikrometer- til mikrometerstørrelse av antimikrobielle midler. Nærmere bestemt gjelder oppfinnelsen et preparat av et antimikrobielt middel som gjør midlet aktivt mot organismer som normalt anses å være resistente overfor midlet. Preparatet omfatter en vandig suspensjon av partikler av submikrometer- til mikrometerstørrelse som inneholder midlet, belagt med minst én surfaktant utvalgt fra gruppen som består av ioniske surfaktanter, ikke-ioniske surfaktanter, biologisk avledede surfaktanter og aminosyrer og deres derivater. Partiklene har en volumveiet gjennomsnittelig partikkelstørrelse på mindre enn 5 (m, målt ved laserdiffraktometri.The present invention relates to preparations of particles of submicrometer to micrometer size of antimicrobial agents. More specifically, the invention relates to a composition of an antimicrobial agent which makes the agent active against organisms which are normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicrometer to micrometer-sized particles containing the agent coated with at least one surfactant selected from the group consisting of ionic surfactants, nonionic surfactants, biologically derived surfactants and amino acids and their derivatives. The particles have a volume weighted average particle size of less than 5 (m, as measured by laser diffractometry).

NO20055616A 2003-04-29 2005-11-28 Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug NO20055616L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46635403P 2003-04-29 2003-04-29
PCT/US2004/013268 WO2004096180A1 (en) 2003-04-29 2004-04-29 Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Publications (2)

Publication Number Publication Date
NO20055616D0 NO20055616D0 (en) 2005-11-28
NO20055616L true NO20055616L (en) 2006-01-25

Family

ID=33418369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055616A NO20055616L (en) 2003-04-29 2005-11-28 Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug

Country Status (11)

Country Link
EP (1) EP1617818A1 (en)
JP (1) JP2006525345A (en)
KR (1) KR20060015553A (en)
CN (1) CN1794975A (en)
AU (1) AU2004234003A1 (en)
BR (1) BRPI0409929A (en)
CA (1) CA2523151A1 (en)
MX (1) MXPA05011607A (en)
NO (1) NO20055616L (en)
WO (1) WO2004096180A1 (en)
ZA (1) ZA200508467B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100858508B1 (en) 2005-12-23 2008-09-12 주식회사 삼양사 Composition comprising azole antifungal drug and a preparation process thereof
JP2009538927A (en) * 2006-05-30 2009-11-12 エラン ファーマ インターナショナル，リミティド Nanoparticulate posaconazole formulation
FR2922107B1 (en) * 2007-10-10 2010-02-26 Aventis Pharma Sa NEW TAXOID COMPOSITIONS
US20090238867A1 (en) * 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
NO2722053T3 (en) * 2010-12-30 2018-03-24
CN102085176A (en) * 2010-12-31 2011-06-08 江苏中丹制药有限公司 Nanometer itraconazole external preparation and preparation method and use thereof
CN102106832A (en) * 2011-02-12 2011-06-29 华中师范大学 Ketoconazole nanometer suspension freeze-dried powder and preparation method thereof
US20190076466A1 (en) * 2015-07-07 2019-03-14 Liferaft Biosciences Reduced sodium poloxamer-188 formulations and methods for use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764001B2 (en) * 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
KR100801588B1 (en) * 1999-09-21 2008-02-05 스키에파마 캐나다 인코포레이티드 Surface Modified Particulate Compositions of Biological Active Substances
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
DK1347747T3 (en) * 2000-12-22 2006-04-10 Baxter Int Process for treating submicroparticle suspensions of pharmaceutical agents
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix

Also Published As

Publication number Publication date
CA2523151A1 (en) 2004-11-11
WO2004096180A1 (en) 2004-11-11
BRPI0409929A (en) 2006-04-25
AU2004234003A1 (en) 2004-11-11
NO20055616D0 (en) 2005-11-28
ZA200508467B (en) 2006-09-27
KR20060015553A (en) 2006-02-17
MXPA05011607A (en) 2005-12-15
JP2006525345A (en) 2006-11-09
EP1617818A1 (en) 2006-01-25
CN1794975A (en) 2006-06-28

Similar Documents

Publication Publication Date Title
NO20055616L (en) Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug
NO20073559L (en) Nanoparticulate tacrolimus formulations
IL145767A0 (en) Microbicidal formulation comprising an essential oil or their derivatives
DE602006016125D1 (en) DISPERSIBLE AGENTS AND COMPOSITIONS THEREOF
DK1471887T3 (en) Nanoparticle compositions having lysozyme as a surface stabilizer
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
DE602005025083D1 (en)
WO2003045344A3 (en) Dentifrice compositions
WO2005002542A3 (en) Nanoparticulate meloxican formulations
DE502005006879D1 (en) WATER-BASED
MX348936B (en) Antibiotic formulations, unit doses, kits, and methods.
DE602004014751D1 (en) CLEANING AGENT OF THE TYPE OF MULTIPLE EMULSION
BR0317554A (en) Controlled release coated peroxygenated compounds, a process for their preparation and use
HK1120794A1 (en) Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
JP2006282629A (en) Spray composition
DE60326263D1 (en) PYRIMIDIN-SULPHONAMIDES AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
RU2007138389A (en) PARASITICIDAL WATER SUSPENSION
JP2011520796A (en) Microemulsion sterilization composition
DK1307445T3 (en) Benzofuran derivatives and their use as antibacterial agents
MY152837A (en) Disinfectant and/or bactericidal aqueous compositions
HUP0301864A2 (en) Phenolate-containing formulation with low freezing point
DE602006001731D1 (en) USE OF PYRIMIDINETRION DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS, COMPOSITIONS AND ITS USES THEREOF
GB0100643D0 (en) Liquid antimicrobial compositions
AU2003286210A1 (en) Smoke composition
ATE341346T1 (en) SPRAY WITH AMPHOTERIC COMPOSITION TO REDUCE ODORS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application